German-Korean Biotech Startup Koralo Announces Clinical Research Update and Expansion Strategy

Brand News 24 | April 27, 2026

German-Korean biotech startup Koralo has announced an update regarding its ongoing research and development activities, alongside its broader operational expansion plans.

The company stated that it recently conducted a clinical study in the United States as part of its continued efforts to develop postbiotic-based ingredients using its proprietary co-fermentation technology. The research forms part of Koralo’s wider initiative to explore applications of fermentation-derived compounds across multiple sectors.

German-Korean Biotech Startup Koralo Announces Clinical Research Update and Expansion Strategy

Koralo is currently operating a manufacturing base in Jeonju, South Korea, where it is leveraging local fermentation infrastructure to support its production and development processes. The facility is expected to play a role in the company’s planned expansion into international markets.

German-Korean Biotech Startup Koralo Announces Clinical Research Update and Expansion Strategy

German-Korean Biotech Startup Koralo Announces Clinical Research Update and Expansion Strategy

According to the company, its co-fermentation platform is being used to develop two product categories—one intended for human food applications and another for aquafeed. Both product lines are derived from a shared production approach, allowing for consistency across applications.

The company noted that its ingredients are designed for integration into a range of formats, including beverages, dairy products, baked goods, dietary supplements, and feed solutions. These developments are part of Koralo’s broader focus on ingredient innovation within the food and feed industries.

German-Korean Biotech Startup Koralo Announces Clinical Research Update and Expansion Strategy

Koralo indicated that it is currently targeting the United States and South Korea for its food-related initiatives, while also exploring opportunities in Europe and Southeast Asia for aquafeed applications.

The company stated that it will continue to focus on research and development of fermentation-based ingredients, with ongoing efforts directed toward expanding its presence in global markets.

Media Contact

Organization: Koralo GmbH (Koralo Co., Ltd.)

Contact Person: Sina Albanese (CEO)

Website: http://www.koralo-foods.com/

Email: Send Email

Country:Korea South

Release id:44299

The post German-Korean Biotech Startup Koralo Announces Clinical Research Update and Expansion Strategy appeared first on King Newswire. This content is provided by a third-party source.. King Newswire is a press release distribution agency. We do not accept any responsibility or liability for the accuracy, content, images, videos, licences, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section above.

file

Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.

disclaimer_press_release